Cerebral Palsy and the Study of Brain Activity During Motor Tasks
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Study ID
- NCT01829724
- Status
- Recruiting
Conditions
- Cerebral Palsy
- Children
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - 100 Years
- Healthy Volunteers
- Accepted
Study Details
Background: \- Two ways to study the brain while people are moving are near-infrared spectroscopy (NIRS) and electroencephalography (EEG). NIRS uses light to look at blood flow in the brain when it is active. EEG records electrical activity in the brain. Both have been used safely for many years, even in very young children. NIRS or EEG can be used while a person is moving to show which parts of the brain are the most active. Researchers want to use NIRS and EEG to study brain activity during movement in people with cerebral palsy and healthy volunteers. Learning more about how people with and without cerebral palsy use their brain to control their muscles may lead to new ways of training people with cerebral palsy to move better. Objectives: \- To study how the brain controls body movement in people with and without cerebral palsy. Eligibility: * Individuals at least 5 years of age who have cerebral palsy. * Healthy volunteers at least 5 years of age. Design: * This study has three parts. People with cerebral palsy will be selected for all three. Healthy volunteers will be asked to do only two of them. Everyone who participates will have NIRS and/or EEG exams during movement. People with cerebral palsy may also have biofeedback sessions to train coordination of movement and brain activity. * Participants will be screened with a physical exam and medical history. Urine samples may be collected. * All participants will have at least one session of NIRS and/or EEG imaging studies. Sessions may also include the following tests: * Magnetic resonance imaging to look at the brain * Electromyography to measure electrical activity of the muscles * Motion analysis of specific body parts * Ultrasound to measure activity of the muscles * Motorized, robotic, and electrical stimulation of the muscles * Other clinical tests of muscle movement as needed. * Participants with cerebral palsy will have biofeedback sessions. These sessions will help them learn to coordinate muscle movement and brain activity.
Key Dates
- Start date
- Aug 22, 2013
- Status verified
- Feb 2026
- Primary completion
- Oct 15, 2028
Study Design
- Enrollment
- 320 participants (estimated)
Arms
- Arm: Healthy volunteerThe control groups for each participant cohort will consist of up to 50 individuals spanning Objectives 1 and 2, for a total recruitment of up to 100 healthy volunteers within the same age range.
- Arm: Individuals with childhood-onset brain or peripheral injuryThe childhood-onset brain injury group 120 individuals spanning the three objectives.
Primary Outcome Measure
changes in brain activation and motor performance in childhood-onset brain injury before and after a short training program. [ Time Frame: real time ]
Central Contacts
- Functional & Applied Biomechanics Sectio(301) 412-5989
- Thomas C Bulea, Ph.D.(301) 451-7533
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
Find similar trials in Bethesda, MD
Related Studies
- The Pediatric Anesthesia Quality Improvement ProjectRecruiting · The Society for Pediatric Anesthesia · Phoenix, Arizona
- Telemedicine in Early Childhood Constraint Therapy in Cerebral PalsyRecruiting · Emory University · Atlanta, Georgia
- Anatomical and Functional Imaging Correlates of Chronic Pain in Cerebral PalsyRecruiting · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Baltimore, Maryland
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaPHASE3 · Recruiting · Bayer · Phoenix, Arizona